425
Participants
Start Date
August 10, 2023
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
secukinumab
Prospective observational study. There is no treatment allocation. Patients administered secukinumab by prescription and administered according to the SmPC.
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Falkensee
Novartis Investigative Site, Brandenburg
Novartis Investigative Site, Panketal
Novartis Investigative Site, Kröpelin
Novartis Investigative Site, Bergen
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Buxtehude
Novartis Investigative Site, Neu Wulmstorf
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Bremen
Novartis Investigative Site, Hanover
Novartis Investigative Site, Bückeburg
Novartis Investigative Site, Minden
Novartis Investigative Site, Bielefeld
Novartis Investigative Site, Hofgeismar
Novartis Investigative Site, Marburg
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Mönchengladbach
Novartis Investigative Site, Wuppertal
Novartis Investigative Site, Remscheid
Novartis Investigative Site, Dortmund
Novartis Investigative Site, Bochum
Novartis Investigative Site, Gladbeck
Novartis Investigative Site, Dorsten
Novartis Investigative Site, Krefeld
Novartis Investigative Site, Kempen
Novartis Investigative Site, Emsdetten
Novartis Investigative Site, Ahaus
Novartis Investigative Site, Lingen Ems
Novartis Investigative Site, Cologne
Novartis Investigative Site, Aachen
Novartis Investigative Site, Stolberg
Novartis Investigative Site, Düren
Novartis Investigative Site, Jülich
Novartis Investigative Site, Geilenkirchen
Novartis Investigative Site, Bonn
Novartis Investigative Site, Wittlich
Novartis Investigative Site, Mainz
Novartis Investigative Site, Mainz
Novartis Investigative Site, Simmern
Novartis Investigative Site, Selters
Novartis Investigative Site, Oelde
Novartis Investigative Site, Unna
Novartis Investigative Site, Soest
Novartis Investigative Site, Karlsruhe
Novartis Investigative Site, Rheinstetten Moersch
Novartis Investigative Site, Baden-Baden
Novartis Investigative Site, Gernsbach
Novartis Investigative Site, Haslach im Kinzigtal
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Freising
Novartis Investigative Site, Nuremberg
Novartis Investigative Site, Nuremberg
Novartis Investigative Site, Oberasbach
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Lauf an der Pegnitz
Novartis Investigative Site, Bad Steben
Novartis Investigative Site, Kulmbach
Novartis Investigative Site, Hasfurt
Novartis Investigative Site, Dresden
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Wittenberg
Novartis Investigative Site, Annaberg-Buchholz
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Delitzsch
Novartis Investigative Site, Dessau
Novartis Investigative Site, Dresden
Novartis Investigative Site, Falkenberg
Novartis Investigative Site, Gera
Novartis Investigative Site, Großenhain
Novartis Investigative Site, Jena
Novartis Investigative Site, Peitz
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY